Colloidal characteristics and formulation of pure protein particulate vaccines

Journal of Pharmacy and Pharmacology

Volumn 64, Issue 10, 2012, Pages 1386-1393

  White, Paul J ^a   Hickey, Pascal ^b   Sze Tu, Linda ^b   Headey, Stephen J ^a   Scanlon, Martin J ^a   Boyd, Ben J ^a   Pouton, Colin W ^a  

^a MONASH UNIVERSITY   (Australia)

^b Telesso Technologies Pty Ltd   (Australia)

Author keywords

dense gas processing; ovalbumin; vaccine

Indexed keywords

DENSE GAS PROCESSED OVALBUMIN; DODECYL SULFATE SODIUM; OVALBUMIN; POLOXAMER; UNCLASSIFIED DRUG;

ARTICLE; COLLOID; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DENSE GAS PROCESSING; DISPERSION; DRUG FORMULATION; DRUG SOLUBILITY; FAST PROTEIN LIQUID CHROMATOGRAPHY; PARTICLE SIZE; PARTICULATE MATTER; PH; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYDISPERSITY; PROTEIN ANALYSIS; PROTEIN DETERMINATION; ROOM TEMPERATURE; VACCINE PRODUCTION; ZETA POTENTIAL;

COLLOIDS; DRUG STABILITY; DRUG STORAGE; EXCIPIENTS; FLOCCULATION; GASES; HYDROGEN-ION CONCENTRATION; OVALBUMIN; PARTICLE SIZE; POLOXAMER; VACCINES;

EID: 84865866335     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/j.2042-7158.2012.01513.x     Document Type: Article

References (18)

1. Sanders MT, et al,. ISCOM-based vaccines: the second decade. Immunol Cell Biol 2005; 83: 119-128.
2. Skene CD, et al,. Evaluation of ISCOMATRIX and ISCOM vaccines for immunisation against Helicobacter pylori. Vaccine 2008; 26: 3880-3884.
3. Skene CD, Sutton P,. Saponin-adjuvanted particulate vaccines for clinical use. Methods 2006; 40: 53-59. (Pubitemid 44415498)
4. Davis ID, et al,. Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4(+) and CD8(+) T cell responses in humans. Proc Natl Acad Sci USA 2004; 101: 10697-10702. (Pubitemid 38955805)
5. Mata-Haro V, et al,. The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4. Science 2007; 316: 1628-1632. (Pubitemid 46982038)
6. Rao JB, et al,. IL-12 is an effective adjuvant to recombinant vaccinia virus-based tumor vaccines: enhancement by simultaneous B7-1 expression. J Immunol 1996; 156: 3357-3365. (Pubitemid 26123552)
7. Pink JR, Kieny MP,. 4th meeting on novel adjuvants currently in/close to Human Clinical Testing World Health Organization-organisation Mondiale de la Sante Fondation Merieux, Annecy, France, 23-25, June 2003. Vaccine 2004; 22: 2097-2102. (Pubitemid 38626045)
8. Uto T, et al,. Targeting of antigen to dendritic cells with poly({gamma}-glutamic acid) nanoparticles induces antigen-specific humoral and cellular immunity. J Immunol 2007; 178: 2979-2986. (Pubitemid 46333177)
9. Xiang SD, et al,. Pathogen recognition and development of particulate vaccines: does size matter? Methods 2006; 40: 1-9. (Pubitemid 44415493)
10. Verrecchia T, et al,. Adsorption/desorption of human serum albumin at the surface of poly(lactic acid) nanoparticles prepared by a solvent evaporation process. J Biomed Mater Res 1993; 27: 1019-1028. (Pubitemid 23206717)
11. Haumont M, et al,. Purification, characterization and immunogenicity of recombinant varicella-zoster virus glycoprotein gE secreted by Chinese hamster ovary cells. Virus Res 1996; 40: 199-204.
12. Koch C, et al,. A comparison of the immunogenicity of the native and denatured forms of a protein. APMIS 1996; 104: 115-125. (Pubitemid 26104753)
13. Schirmbeck R, et al,. Injection of detergent-denatured ovalbumin primes murine class I-restricted cytotoxic T cells in vivo. Eur J Immunol 1994; 24: 2068-2072. (Pubitemid 24276536)
14. Liu HL, et al,. Molecular dynamics simulations to determine the effect of supercritical carbon dioxide on the structural integrity of hen egg white lysozyme. Biotechnol Prog 2004; 20: 930-938.
15. Winters MA, et al,. Long-term and high-temperature storage of supercritically-processed microparticulate protein powders. Pharm Res 1997; 14: 1370-1378. (Pubitemid 27481068)
16. Winters MA, et al,. Precipitation of proteins in supercritical carbon dioxide. J Pharm Sci 1996; 85: 586-594. (Pubitemid 26179098)
17. White PJ, et al,. Generic construction of single component particles that elicit humoural and cellular immune responses without the need for adjuvants. Vaccine 2008; 26: 6824-6831.
18. Smith ER,. The effect of variations in ionic strength on the apparent isoelectric point of egg albumin. J Biol Chem 1935; 108: 187-194.